Clinical Trial Detail

NCT ID NCT01107626
Title Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Eastern Cooperative Oncology Group
Indications

lung non-small cell carcinoma

Therapies

Pemetrexed Disodium

Bevacizumab

Age Groups: adult

No variant requirements are available.